Skip to main content

Table 6 Area under the curve for training, tenfold cross-validation and independent validation on 13-SNP model

From: Clinical validation of a genetic model to estimate the risk of developing choroidal neovascular age-related macular degeneration

Stage Control/
CNV
ROC
area
Standard
error
Confidence
limits
Training 467/482 0.82 0.01 0.79 0.85
Tenfold
cross-
validation
467/482 0.81 0.01 0.79 0.84
Validation 322/632 0.80 0.02 0.77 0.83
  1. SNP, single nucleotide polymorphism; CNV, choroidal neovascular; ROC, receiver operating characteristic